Alvotech appointed Patrik Ling as VP of Investor Relations, while DNB Carnegie covered life science companies including Alvotech.
1 report, 1 independent
Updated Aug 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alvotech appointed Patrik Ling as VP of Investor Relations, while DNB Carnegie covered life science companies including Alvotech.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Alvotech
biotechnology company
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireAlvotech appoints Patrik Ling as VP of Investor Relations Scandinavia REYKJAVIK, ICELAND (August 20, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manu